GALM

UniProt ID: Q96C23
Organism: Homo sapiens
Review Status: IN PROGRESS
📝 Provide Detailed Feedback

Gene Description

GALM is the cytosolic aldose 1-epimerase (galactose mutarotase; EC 5.1.3.3) that catalyzes the first step of the Leloir pathway of galactose metabolism. It interconverts the beta- and alpha-anomers of D-galactose (beta-D-galactose <=> alpha-D-galactose), maintaining the anomeric equilibrium and ensuring a sufficient supply of the alpha-anomer, which galactokinase (GALK1) requires as its substrate; the downstream Leloir enzymes GALK1, GALT, and GALE then convert galactose into glucose 1-phosphate. GALM also mutarotates D-glucose (alpha-D-glucose <=> beta-D-glucose), though it prefers galactose over glucose. The enzyme is a monomer with a single-domain beta-sandwich fold typical of the aldose epimerase family; catalysis uses His-176 as the proton donor and Glu-307 as the proton acceptor, with His-107 also contributing. Biallelic loss-of-function GALM variants cause galactose mutarotase deficiency (galactosemia type IV, GALAC4), an autosomal recessive inborn error of galactose metabolism.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) inference that GALM participates in the Leloir pathway of galactose catabolism. This is the core biological process of GALM: it catalyzes the first (mutarotase) step supplying alpha-D-galactose to GALK1.
Reason: Consistent with the experimentally established Leloir-pathway role and the PANTHER aldose-1-epimerase family. Represents a core function.
GO:0004034 aldose 1-epimerase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) inference of aldose 1-epimerase activity, the core molecular function of GALM, matching the family-level assignment for PTN000009552.
Reason: The defining catalytic activity of GALM, independently supported by direct experimental characterization (PMID:12753898). Core molecular function.
GO:0006006 glucose metabolic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetic inference that GALM participates in glucose metabolism, reflecting the family's ability to mutarotate glucose in addition to galactose.
Reason: GALM does mutarotate D-glucose in vitro, but with lower affinity/turnover than galactose (KM 54 mM vs 37 mM; kcat 4900 vs 12000 s-1), and the enzyme "exhibits a preference for galactose over glucose" (PMID:12753898). Glucose mutarotation is a genuine but secondary activity, not the core physiological role.
Supporting Evidence:
PMID:12753898
the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose
GO:0004034 aldose 1-epimerase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (RHEA/EC 5.1.3.3) assignment of aldose 1-epimerase activity, the core molecular function.
Reason: Correctly mapped from EC 5.1.3.3 / RHEA:10264,RHEA:28675 to the specific MF term; matches experimental evidence.
GO:0005737 cytoplasm
IEA
GO_REF:0000044
ACCEPT
Summary: Subcellular-location mapping (UniProt SL-0086) placing GALM in the cytoplasm.
Reason: Consistent with the UniProt subcellular location (Cytoplasm) and the Reactome cytosol annotation. Broader than cytosol but not incorrect.
GO:0005975 carbohydrate metabolic process
IEA
GO_REF:0000002
KEEP AS NON CORE
Summary: InterPro2GO mapping to the high-level carbohydrate metabolic process, from the aldose epimerase domains.
Reason: True but a very general grouping term. The specific galactose/hexose processes below are more informative; retained as a non-core parent.
GO:0016853 isomerase activity
IEA
GO_REF:0000002
MODIFY
Summary: InterPro2GO mapping to the generic parent term isomerase activity.
Reason: Correct but overly general: GALM's activity is specifically aldose 1-epimerase activity (GO:0004034), which is a descendant of isomerase activity and is already annotated with strong experimental support. Replace the generic parent with the specific MF.
Proposed replacements: aldose 1-epimerase activity
GO:0019318 hexose metabolic process
IEA
GO_REF:0000120
KEEP AS NON CORE
Summary: Automated mapping (UniPathway/InterPro) to hexose metabolic process, consistent with GALM acting on the hexoses galactose and glucose.
Reason: Accurate parent term encompassing galactose and glucose metabolism, but less specific than the galactose process terms. Retained as a non-core grouping term.
GO:0030246 carbohydrate binding
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: InterPro2GO mapping to carbohydrate binding, derived from the sugar-binding beta-sandwich (GH-type carbohydrate-binding) domain signatures.
Reason: GALM binds galactose/glucose only transiently as catalytic substrates in its active site, not as a lectin-type carbohydrate-binding module. GO:0030246 (carbohydrate binding) implies a dedicated binding function distinct from catalysis; this is an over-annotation propagated from the structural fold signature. The catalytic substrate interaction is already captured by the aldose 1-epimerase activity annotation.
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
TAS
Reactome:R-HSA-70370
ACCEPT
Summary: Reactome-curated (TAS) assignment of GALM to the Leloir pathway of galactose catabolism.
Reason: Curator-asserted pathway membership matching the established biology; core biological process.
GO:0006012 galactose metabolic process
IEA
GO_REF:0000041
ACCEPT
Summary: UniPathway-based (UPA00214) mapping to galactose metabolic process.
Reason: Core biological process of GALM; the anomer interconversion it catalyzes initiates galactose metabolism. Independently supported by IDA (PMID:12753898).
GO:0004034 aldose 1-epimerase activity
EXP
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Experimental demonstration that recombinant human GALM has aldose 1-epimerase activity, with confirmed catalytic residues.
Reason: Core molecular function, directly demonstrated by enzyme assays on purified recombinant protein plus site-directed mutagenesis of catalytic residues.
Supporting Evidence:
PMID:12753898
Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding.
GO:0004034 aldose 1-epimerase activity
TAS
Reactome:R-HSA-9931926
ACCEPT
Summary: Reactome-curated (TAS) assertion of aldose 1-epimerase activity (in the context of the defective-GALM reaction).
Reason: Core molecular function; consistent with all other MF evidence.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9931853
ACCEPT
Summary: Reactome-curated (TAS) localization of GALM (the "GALM converts beta-D-GAL to alpha-D-GAL" reaction) to the cytosol.
Reason: Consistent with the cytoplasmic Leloir pathway; the most specific and appropriate location term for GALM. Core localization.
GO:0005829 cytosol
TAS
Reactome:R-HSA-9931926
ACCEPT
Summary: Reactome-curated (TAS) cytosol localization (defective-GALM reaction context). Duplicate of the preceding cytosol annotation from a related Reactome reaction.
Reason: Correct core localization; duplicate assertion of cytosol is acceptable.
GO:0004034 aldose 1-epimerase activity
IDA
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Direct assay (IDA) of aldose 1-epimerase activity in the study that identified GALM deficiency as a novel galactosemia; patient/variant proteins showed altered activity.
Reason: Core molecular function, independently confirmed in the disease-gene study.
GO:0004034 aldose 1-epimerase activity
IMP
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence that pathogenic GALM variants reduce aldose 1-epimerase activity, linking loss of this MF to disease.
Reason: Loss-of-function variants causing galactosemia type IV support the physiological relevance of this core molecular function.
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
IMP
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Mutant-phenotype (IMP) evidence that GALM loss disrupts the Leloir pathway of galactose catabolism, causing galactose accumulation / galactosemia type IV.
Reason: Biallelic GALM variants cause a novel type of galactosemia by impairing the Leloir pathway; core biological process supported by human disease genetics.
GO:0033499 beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
IDA
PMID:30451973
Biallelic GALM pathogenic variants cause a novel type of gal...
ACCEPT
Summary: Direct-assay (IDA) evidence supporting GALM's participation in the Leloir galactose catabolic pathway.
Reason: Core biological process, directly supported. Duplicate of the IBA/TAS Leloir-pathway annotations with independent experimental backing.
GO:0004034 aldose 1-epimerase activity
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Direct assay (IDA) of aldose 1-epimerase activity on purified recombinant human GALM.
Reason: Core molecular function; the foundational biochemical characterization of the enzyme.
Supporting Evidence:
PMID:12753898
Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose.
GO:0005975 carbohydrate metabolic process
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
KEEP AS NON CORE
Summary: Direct-assay evidence placing GALM in carbohydrate metabolism (mutarotation of hexose sugars), a high-level grouping process.
Reason: Correct but very general; the specific galactose/glucose metabolic process terms are more informative. Retained as a non-core parent. GALM is described as "a key enzyme of carbohydrate metabolism" (PMID:12753898).
Supporting Evidence:
PMID:12753898
Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose.
GO:0042803 protein homodimerization activity
IDA NOT
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Negated (NOT) annotation: GALM does not have protein homodimerization activity. Biochemical and structural characterization established that GALM is a monomer.
Reason: The NOT annotation correctly records that GALM does not homodimerize. UniProt reports the SUBUNIT as Monomer (from PMID:12753898 and PMID:15026423). Retaining the negation is informative and consistent with the monomeric solution and crystal state.
GO:0070062 extracellular exosome
HDA
PMID:19056867
Large-scale proteomics and phosphoproteomics of urinary exos...
KEEP AS NON CORE
Summary: High-throughput mass-spectrometry (HDA) detection of GALM among proteins recovered from human urinary exosomes.
Reason: Reflects broad proteomic detection in secreted exosomes rather than the enzyme's site of catalytic function, which is the cytosol. Kept as a non-core localization; not part of the core Leloir-pathway function.
Supporting Evidence:
PMID:19056867
we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously
GO:0006006 glucose metabolic process
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
KEEP AS NON CORE
Summary: Direct-assay evidence that GALM mutarotates D-glucose, participating in glucose metabolism.
Reason: GALM does interconvert glucose anomers, but with lower efficiency than galactose and a demonstrated preference for galactose (PMID:12753898). A real but secondary activity, not the core physiological role.
Supporting Evidence:
PMID:12753898
catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose
GO:0006012 galactose metabolic process
IDA
PMID:12753898
Identification and characterisation of human aldose 1-epimer...
ACCEPT
Summary: Direct-assay evidence that GALM participates in galactose metabolism via mutarotation of galactose anomers.
Reason: Core biological process; directly demonstrated and consistent with the enzyme's preference for galactose. Foundational to the Leloir pathway.
Supporting Evidence:
PMID:12753898
catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose

Core Functions

Aldose 1-epimerase (galactose mutarotase) activity: GALM interconverts the beta- and alpha-anomers of D-galactose in the cytosol, catalyzing the first step of the Leloir pathway and supplying the alpha-D-galactose required by galactokinase (GALK1).

Supporting Evidence:
  • PMID:12753898
    Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose.
  • PMID:30451973
    Biallelic GALM pathogenic variants cause a novel type of galactosemia.

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniPathway vocabulary mapping
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Combined Automated Annotation using Multiple IEA Methods
Identification and characterisation of human aldose 1-epimerase.
  • Recombinant human GALM has aldose 1-epimerase (mutarotase) activity (EC 5.1.3.3) and interconverts the alpha- and beta-anomers of hexose sugars, with a preference for galactose over glucose; site-directed mutagenesis confirmed catalytic/substrate-binding residues.
    "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding."
Large-scale proteomics and phosphoproteomics of urinary exosomes.
  • Large-scale LC-MS/MS proteomics of human urinary exosomes; GALM is among the many proteins detected in this exosome fraction.
    "we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously"
Biallelic GALM pathogenic variants cause a novel type of galactosemia.
  • Biallelic loss-of-function GALM variants impair aldose 1-epimerase activity and the Leloir pathway, causing a novel (type IV) galactosemia (galactose mutarotase deficiency, GALAC4).
    "Biallelic GALM pathogenic variants cause a novel type of galactosemia."
Reactome:R-HSA-70370
Galactose catabolism
Reactome:R-HSA-9931853
GALM converts beta-D-GAL to alpha-D-GAL
Reactome:R-HSA-9931926
Defective GALM doesn't convert beta-D-GAL to alpha-D-GAL

📚 Additional Documentation

Notes

(GALM-notes.md)

GALM (galactose mutarotase / aldose 1-epimerase) — review notes

UniProtKB: Q96C23; HGNC:24063; EC 5.1.3.3; 342 aa; PDB 1SNZ/1SO0.

Core biology (verified from UniProt + cached pubs)

  • GALM is the cytosolic aldose 1-epimerase (mutarotase) that catalyses the FIRST step of the
    Leloir pathway of galactose metabolism: interconversion of the β- and α-anomers of D-galactose,
    supplying the α-anomer that galactokinase (GALK1) requires.
    [UniProt FUNCTION: "Mutarotase that catalyzes the interconversion of beta-D-galactose and alpha-D-galactose during galactose metabolism (PubMed:12753898)... Involved in the maintenance of the equilibrium between the beta- and alpha-anomers of galactose, therefore ensuring a sufficient supply of the alpha-anomer for GALK1"]
  • Leloir pathway enzymes: GALM, GALK1, GALT, GALE [UniProt FUNCTION, PMID:30451973].
  • Also active on D-glucose (α-D-glucose ⇌ β-D-glucose) but prefers galactose over glucose
    [PMID:12753898 abstract: "the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose"; UniProt KM=37 mM galactose vs 54 mM glucose; kcat 12000 vs 4900 s^-1].
  • Catalytic residues: His-176 (proton donor / ACT_SITE), Glu-307 (proton acceptor / ACT_SITE), His-107.
    Mutagenesis: H176A -300x, E307A loss of activity, H107A -5x [UniProt FEATURES / PMID:12753898].
  • Monomer (SUBUNIT: Monomer, PMID:12753898 + PMID:15026423). GOA carries a NOT protein
    homodimerization activity (GO:0042803) IDA — consistent with monomeric state; keep negated.
  • Subcellular location: Cytoplasm (UniProt SL). Reactome places the reaction in cytosol (GO:0005829). Also detected in urinary exosomes by MS (GO:0070062, PMID:19056867) — MS-detected, non-core.

Disease

  • Biallelic GALM variants cause Galactosemia type IV (GALAC4 / galactose mutarotase deficiency),
    MIM:618881, Orphanet:570422 — a form of galactosemia PMID:30451973. GALAC4 variants (82-342 del,
    R142, G267, 311-342 del) reduce protein stability/accumulation and epimerase activity [UniProt VARIANTs].
  • Note: the dismech Galactosemia.yaml (classic/GALK/GALE subtypes) predates/omits the GALM (type IV) form;
    GALM deficiency is the fourth Leloir-pathway galactosemia.

Annotation-review reasoning

  • GO:0004034 aldose 1-epimerase activity — CORE MF; multiple EXP/IDA/IMP/IBA/TAS + IEA(RHEA/EC). ACCEPT all.
  • GO:0033499 (galactose catabolic process via UDP-galactose, Leloir pathway) — core BP. IBA/TAS/IMP/IDA. ACCEPT.
    (Stub label "beta-D-galactose catabolic process..." matches GOA TSV; current ontology primary label
    is "galactose catabolic process via UDP-galactose, Leloir pathway" — keep GOA label to match best-practices check.)
  • GO:0006012 galactose metabolic process — core BP (IDA PMID:12753898 + IEA UniPathway). ACCEPT.
  • GO:0019318 hexose metabolic process, GO:0005975 carbohydrate metabolic process — true but general parents;
    KEEP_AS_NON_CORE (grouping terms).
  • GO:0006006 glucose metabolic process — GALM mutarotates glucose (IDA PMID:12753898, IBA). Real but non-core
    (prefers galactose; glucose mutarotation is a side/secondary activity). KEEP_AS_NON_CORE.
  • GO:0016853 isomerase activity (IEA/InterPro) — generic parent of aldose 1-epimerase; MODIFY -> GO:0004034.
  • GO:0030246 carbohydrate binding (IEA/InterPro) — lectin-type binding term; GALM binds galactose only as a
    catalytic substrate, not as a lectin. Over-annotation from InterPro2GO. MARK_AS_OVER_ANNOTATED.
  • GO:0005829 cytosol (TAS Reactome) — ACCEPT (core location).
  • GO:0005737 cytoplasm (IEA SubCell) — ACCEPT (broader, consistent).
  • GO:0070062 extracellular exosome (HDA PMID:19056867) — MS detection in urinary exosomes; KEEP_AS_NON_CORE.
  • GO:0042803 protein homodimerization activity, negated=true (IDA PMID:12753898) — GALM is a monomer;
    the NOT annotation is correct. ACCEPT.

Cached pubs (PMID_12753898, PMID_30451973, PMID_19056867) are all abstract-only (full_text_available: false).
Do not REMOVE experimental annotations on the basis of abstract-only text.

📄 View Raw YAML

id: Q96C23
gene_symbol: GALM
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: >-
  GALM is the cytosolic aldose 1-epimerase (galactose mutarotase; EC 5.1.3.3) that
  catalyzes the first step of the Leloir pathway of galactose metabolism. It interconverts
  the beta- and alpha-anomers of D-galactose (beta-D-galactose <=> alpha-D-galactose),
  maintaining the anomeric equilibrium and ensuring a sufficient supply of the alpha-anomer,
  which galactokinase (GALK1) requires as its substrate; the downstream Leloir enzymes GALK1,
  GALT, and GALE then convert galactose into glucose 1-phosphate. GALM also mutarotates
  D-glucose (alpha-D-glucose <=> beta-D-glucose), though it prefers galactose over glucose.
  The enzyme is a monomer with a single-domain beta-sandwich fold typical of the aldose
  epimerase family; catalysis uses His-176 as the proton donor and Glu-307 as the proton
  acceptor, with His-107 also contributing. Biallelic loss-of-function GALM variants cause
  galactose mutarotase deficiency (galactosemia type IV, GALAC4), an autosomal recessive
  inborn error of galactose metabolism.
existing_annotations:
- term:
    id: GO:0033499
    label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic (IBA) inference that GALM participates in the Leloir pathway of galactose
      catabolism. This is the core biological process of GALM: it catalyzes the first (mutarotase)
      step supplying alpha-D-galactose to GALK1.
    action: ACCEPT
    reason: >-
      Consistent with the experimentally established Leloir-pathway role and the PANTHER
      aldose-1-epimerase family. Represents a core function.
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: >-
      Phylogenetic (IBA) inference of aldose 1-epimerase activity, the core molecular function
      of GALM, matching the family-level assignment for PTN000009552.
    action: ACCEPT
    reason: >-
      The defining catalytic activity of GALM, independently supported by direct experimental
      characterization (PMID:12753898). Core molecular function.
- term:
    id: GO:0006006
    label: glucose metabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: >-
      Phylogenetic inference that GALM participates in glucose metabolism, reflecting the
      family's ability to mutarotate glucose in addition to galactose.
    action: KEEP_AS_NON_CORE
    reason: >-
      GALM does mutarotate D-glucose in vitro, but with lower affinity/turnover than galactose
      (KM 54 mM vs 37 mM; kcat 4900 vs 12000 s-1), and the enzyme "exhibits a preference for
      galactose over glucose" (PMID:12753898). Glucose mutarotation is a genuine but secondary
      activity, not the core physiological role.
    supported_by:
    - reference_id: PMID:12753898
      supporting_text: "the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose"
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: >-
      Automated (RHEA/EC 5.1.3.3) assignment of aldose 1-epimerase activity, the core molecular
      function.
    action: ACCEPT
    reason: >-
      Correctly mapped from EC 5.1.3.3 / RHEA:10264,RHEA:28675 to the specific MF term; matches
      experimental evidence.
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: >-
      Subcellular-location mapping (UniProt SL-0086) placing GALM in the cytoplasm.
    action: ACCEPT
    reason: >-
      Consistent with the UniProt subcellular location (Cytoplasm) and the Reactome cytosol
      annotation. Broader than cytosol but not incorrect.
- term:
    id: GO:0005975
    label: carbohydrate metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: >-
      InterPro2GO mapping to the high-level carbohydrate metabolic process, from the aldose
      epimerase domains.
    action: KEEP_AS_NON_CORE
    reason: >-
      True but a very general grouping term. The specific galactose/hexose processes below are
      more informative; retained as a non-core parent.
- term:
    id: GO:0016853
    label: isomerase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro2GO mapping to the generic parent term isomerase activity.
    action: MODIFY
    reason: >-
      Correct but overly general: GALM's activity is specifically aldose 1-epimerase activity
      (GO:0004034), which is a descendant of isomerase activity and is already annotated with
      strong experimental support. Replace the generic parent with the specific MF.
    proposed_replacement_terms:
    - id: GO:0004034
      label: aldose 1-epimerase activity
- term:
    id: GO:0019318
    label: hexose metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: >-
      Automated mapping (UniPathway/InterPro) to hexose metabolic process, consistent with GALM
      acting on the hexoses galactose and glucose.
    action: KEEP_AS_NON_CORE
    reason: >-
      Accurate parent term encompassing galactose and glucose metabolism, but less specific than
      the galactose process terms. Retained as a non-core grouping term.
- term:
    id: GO:0030246
    label: carbohydrate binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: >-
      InterPro2GO mapping to carbohydrate binding, derived from the sugar-binding beta-sandwich
      (GH-type carbohydrate-binding) domain signatures.
    action: MARK_AS_OVER_ANNOTATED
    reason: >-
      GALM binds galactose/glucose only transiently as catalytic substrates in its active site,
      not as a lectin-type carbohydrate-binding module. GO:0030246 (carbohydrate binding) implies
      a dedicated binding function distinct from catalysis; this is an over-annotation propagated
      from the structural fold signature. The catalytic substrate interaction is already captured
      by the aldose 1-epimerase activity annotation.
- term:
    id: GO:0033499
    label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-70370
  qualifier: involved_in
  review:
    summary: >-
      Reactome-curated (TAS) assignment of GALM to the Leloir pathway of galactose catabolism.
    action: ACCEPT
    reason: >-
      Curator-asserted pathway membership matching the established biology; core biological process.
- term:
    id: GO:0006012
    label: galactose metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000041
  qualifier: involved_in
  review:
    summary: >-
      UniPathway-based (UPA00214) mapping to galactose metabolic process.
    action: ACCEPT
    reason: >-
      Core biological process of GALM; the anomer interconversion it catalyzes initiates galactose
      metabolism. Independently supported by IDA (PMID:12753898).
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: EXP
  original_reference_id: PMID:12753898
  qualifier: enables
  review:
    summary: >-
      Experimental demonstration that recombinant human GALM has aldose 1-epimerase activity,
      with confirmed catalytic residues.
    action: ACCEPT
    reason: >-
      Core molecular function, directly demonstrated by enzyme assays on purified recombinant
      protein plus site-directed mutagenesis of catalytic residues.
    supported_by:
    - reference_id: PMID:12753898
      supporting_text: "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding."
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9931926
  qualifier: enables
  review:
    summary: >-
      Reactome-curated (TAS) assertion of aldose 1-epimerase activity (in the context of the
      defective-GALM reaction).
    action: ACCEPT
    reason: >-
      Core molecular function; consistent with all other MF evidence.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9931853
  qualifier: located_in
  review:
    summary: >-
      Reactome-curated (TAS) localization of GALM (the "GALM converts beta-D-GAL to alpha-D-GAL"
      reaction) to the cytosol.
    action: ACCEPT
    reason: >-
      Consistent with the cytoplasmic Leloir pathway; the most specific and appropriate location
      term for GALM. Core localization.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9931926
  qualifier: located_in
  review:
    summary: >-
      Reactome-curated (TAS) cytosol localization (defective-GALM reaction context). Duplicate of
      the preceding cytosol annotation from a related Reactome reaction.
    action: ACCEPT
    reason: >-
      Correct core localization; duplicate assertion of cytosol is acceptable.
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: IDA
  original_reference_id: PMID:30451973
  qualifier: enables
  review:
    summary: >-
      Direct assay (IDA) of aldose 1-epimerase activity in the study that identified GALM
      deficiency as a novel galactosemia; patient/variant proteins showed altered activity.
    action: ACCEPT
    reason: >-
      Core molecular function, independently confirmed in the disease-gene study.
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: IMP
  original_reference_id: PMID:30451973
  qualifier: enables
  review:
    summary: >-
      Mutant-phenotype (IMP) evidence that pathogenic GALM variants reduce aldose 1-epimerase
      activity, linking loss of this MF to disease.
    action: ACCEPT
    reason: >-
      Loss-of-function variants causing galactosemia type IV support the physiological relevance
      of this core molecular function.
- term:
    id: GO:0033499
    label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
  evidence_type: IMP
  original_reference_id: PMID:30451973
  qualifier: acts_upstream_of_or_within
  review:
    summary: >-
      Mutant-phenotype (IMP) evidence that GALM loss disrupts the Leloir pathway of galactose
      catabolism, causing galactose accumulation / galactosemia type IV.
    action: ACCEPT
    reason: >-
      Biallelic GALM variants cause a novel type of galactosemia by impairing the Leloir pathway;
      core biological process supported by human disease genetics.
- term:
    id: GO:0033499
    label: beta-D-galactose catabolic process via UDP-galactose, Leloir pathway
  evidence_type: IDA
  original_reference_id: PMID:30451973
  qualifier: involved_in
  review:
    summary: >-
      Direct-assay (IDA) evidence supporting GALM's participation in the Leloir galactose
      catabolic pathway.
    action: ACCEPT
    reason: >-
      Core biological process, directly supported. Duplicate of the IBA/TAS Leloir-pathway
      annotations with independent experimental backing.
- term:
    id: GO:0004034
    label: aldose 1-epimerase activity
  evidence_type: IDA
  original_reference_id: PMID:12753898
  qualifier: enables
  review:
    summary: >-
      Direct assay (IDA) of aldose 1-epimerase activity on purified recombinant human GALM.
    action: ACCEPT
    reason: >-
      Core molecular function; the foundational biochemical characterization of the enzyme.
    supported_by:
    - reference_id: PMID:12753898
      supporting_text: "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose."
- term:
    id: GO:0005975
    label: carbohydrate metabolic process
  evidence_type: IDA
  original_reference_id: PMID:12753898
  qualifier: acts_upstream_of_or_within
  review:
    summary: >-
      Direct-assay evidence placing GALM in carbohydrate metabolism (mutarotation of hexose
      sugars), a high-level grouping process.
    action: KEEP_AS_NON_CORE
    reason: >-
      Correct but very general; the specific galactose/glucose metabolic process terms are more
      informative. Retained as a non-core parent. GALM is described as "a key enzyme of
      carbohydrate metabolism" (PMID:12753898).
    supported_by:
    - reference_id: PMID:12753898
      supporting_text: "Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose."
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:12753898
  qualifier: enables
  negated: true
  review:
    summary: >-
      Negated (NOT) annotation: GALM does not have protein homodimerization activity. Biochemical
      and structural characterization established that GALM is a monomer.
    action: ACCEPT
    reason: >-
      The NOT annotation correctly records that GALM does not homodimerize. UniProt reports the
      SUBUNIT as Monomer (from PMID:12753898 and PMID:15026423). Retaining the negation is
      informative and consistent with the monomeric solution and crystal state.
- term:
    id: GO:0070062
    label: extracellular exosome
  evidence_type: HDA
  original_reference_id: PMID:19056867
  qualifier: located_in
  review:
    summary: >-
      High-throughput mass-spectrometry (HDA) detection of GALM among proteins recovered from
      human urinary exosomes.
    action: KEEP_AS_NON_CORE
    reason: >-
      Reflects broad proteomic detection in secreted exosomes rather than the enzyme's site of
      catalytic function, which is the cytosol. Kept as a non-core localization; not part of the
      core Leloir-pathway function.
    supported_by:
    - reference_id: PMID:19056867
      supporting_text: "we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously"
- term:
    id: GO:0006006
    label: glucose metabolic process
  evidence_type: IDA
  original_reference_id: PMID:12753898
  qualifier: involved_in
  review:
    summary: >-
      Direct-assay evidence that GALM mutarotates D-glucose, participating in glucose metabolism.
    action: KEEP_AS_NON_CORE
    reason: >-
      GALM does interconvert glucose anomers, but with lower efficiency than galactose and a
      demonstrated preference for galactose (PMID:12753898). A real but secondary activity, not
      the core physiological role.
    supported_by:
    - reference_id: PMID:12753898
      supporting_text: "catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose"
- term:
    id: GO:0006012
    label: galactose metabolic process
  evidence_type: IDA
  original_reference_id: PMID:12753898
  qualifier: involved_in
  review:
    summary: >-
      Direct-assay evidence that GALM participates in galactose metabolism via mutarotation of
      galactose anomers.
    action: ACCEPT
    reason: >-
      Core biological process; directly demonstrated and consistent with the enzyme's preference
      for galactose. Foundational to the Leloir pathway.
    supported_by:
    - reference_id: PMID:12753898
      supporting_text: "catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose"
core_functions:
- description: >-
    Aldose 1-epimerase (galactose mutarotase) activity: GALM interconverts the beta- and
    alpha-anomers of D-galactose in the cytosol, catalyzing the first step of the Leloir pathway
    and supplying the alpha-D-galactose required by galactokinase (GALK1).
  molecular_function:
    id: GO:0004034
    label: aldose 1-epimerase activity
  directly_involved_in:
  - id: GO:0033499
    label: galactose catabolic process via UDP-galactose, Leloir pathway
  - id: GO:0006012
    label: galactose metabolic process
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: PMID:12753898
    supporting_text: "Aldose 1-epimerase or mutarotase (EC 5.1.3.3) is a key enzyme of carbohydrate metabolism catalysing the interconversion of the alpha- and beta-anomers of hexose sugars such as glucose and galactose."
  - reference_id: PMID:30451973
    supporting_text: "Biallelic GALM pathogenic variants cause a novel type of galactosemia."
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000041
  title: Gene Ontology annotation based on UniPathway vocabulary mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary
    mapping, accompanied by conservative changes to GO terms applied by UniProt
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:12753898
  title: Identification and characterisation of human aldose 1-epimerase.
  findings:
  - statement: >-
      Recombinant human GALM has aldose 1-epimerase (mutarotase) activity (EC 5.1.3.3) and
      interconverts the alpha- and beta-anomers of hexose sugars, with a preference for galactose
      over glucose; site-directed mutagenesis confirmed catalytic/substrate-binding residues.
    supporting_text: "Enzyme assays show that the protein has aldose 1-epimerase activity and exhibits a preference for galactose over glucose. Site-directed mutagenesis confirmed the involvement of three residues involved in catalysis and substrate binding."
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Abstract-only in cache (full_text_available: false), but the abstract directly establishes
      GALM's core aldose 1-epimerase activity and galactose preference; PMID matches title.
- id: PMID:19056867
  title: Large-scale proteomics and phosphoproteomics of urinary exosomes.
  findings:
  - statement: >-
      Large-scale LC-MS/MS proteomics of human urinary exosomes; GALM is among the many proteins
      detected in this exosome fraction.
    supporting_text: "we used LC-MS/MS to profile the proteome of human urinary exosomes. Overall, the analysis identified 1132 proteins unambiguously"
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: >-
      High-throughput proteomics survey supporting only the extracellular-exosome detection
      (non-core); does not inform GALM's catalytic function.
- id: PMID:30451973
  title: Biallelic GALM pathogenic variants cause a novel type of galactosemia.
  findings:
  - statement: >-
      Biallelic loss-of-function GALM variants impair aldose 1-epimerase activity and the Leloir
      pathway, causing a novel (type IV) galactosemia (galactose mutarotase deficiency, GALAC4).
    supporting_text: "Biallelic GALM pathogenic variants cause a novel type of galactosemia."
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: >-
      Abstract-only in cache; establishes the disease relevance (galactosemia type IV) and, via
      variant characterization, supports GALM's role in the Leloir galactose catabolic pathway.
- id: Reactome:R-HSA-70370
  title: Galactose catabolism
  findings: []
- id: Reactome:R-HSA-9931853
  title: GALM converts beta-D-GAL to alpha-D-GAL
  findings: []
- id: Reactome:R-HSA-9931926
  title: Defective GALM doesn't convert beta-D-GAL to alpha-D-GAL
  findings: []